Amgen Worldwide
A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
A biotechnology pioneer since 1980, Amgen has reached millions of patients around the world.
Making a positive impact to our patients and the world is at the heart of what we do at Amgen – and this goes beyond making vital medicines. Each year, Amgen and our staff members dedicate significant resources towards building a better tomorrow.
At Amgen, we discover, develop and manufacture medicines to enable more moments in the lives of more people. For moments like these, Amgen innovates and works – boldly, tirelessly and passionately – to serve the ones that matter: patients.
Amgen Hong Kong uses the tools of modern science and biology to address the most serious diseases facing people. We are committed to creating healthcare solutions to those we serve and breaking down barriers to healthcare access through patient empowerment. Besides working with regional and local stakeholders to promote healthcare systems that work and save costs, Amgen Hong Kong also partners with local non-governmental organizations to run patient assistance programs, allowing patients to access appropriate treatment and timely care throughout their treatment journey.
Echoing Amgen Hong Kong's mission to further the advancement of healthcare and health literacy, we have invested substantially in medical education since 2016. With the aim of sharing and imparting pertinent scientific knowledge to the community, Amgen Hong Kong also partners with patient groups to deliver disease education programs to the general public.
Furthermore, the Amgen Foundation, established in 1991, seeks to advance excellence in science education to inspire the next generation of innovators and strengthen communities where Amgen staff live and work. The Foundation is the principal channel for Amgen’s corporate philanthropy. To date, it has contributed more than US$200 million to advancing science education programming globally, including Amgen Biotech Experience (ABE), Amgen Scholars, Khan Academy and LabXchange.
Learn more about the Amgen Foundation at www.amgeninspires.com.
Partnering with the Chinese University of Hong Kong, ABE Hong Kong is tailored to enrich the Diploma of Secondary Education biology curriculum. It fills the gap between theory learning and practical work, as well as constituting an important part of science, technology, engineering and mathematics (STEM) education. Since 2016, the program has reached 43 schools, 85 teachers, 73 school lab technicians and over 2,900 students.
Through ABE Hong Kong, Amgen nurtures a community of science teachers with pedagogical, curricular and technical competencies in biotechnology education, and ultimately promote biotechnology as a key element of science learning in Hong Kong.
Find out more about ABE Hong Kong at https://amgenbiotechexperience.net/hk/.
Launched in 2006, Amgen Scholars opens the opportunity for undergraduate students to apply for a summer science learning experience. Students engage in cutting-edge research experiences and learn more about biotechnology and drug discovery. In JAPAC, four renowned universities have hosted this Program: Kyoto University and The University of Tokyo in Japan, National University of Singapore in Singapore, and Tsinghua University in China. The program committed US$74 million over 17 years, this significant commitment has made it possible for over 4,400 students to date to be an Amgen Scholar, in addition to another 1,100 students who will have this opportunity over the coming years.
Learn more about the program, participating research institutions, and how to apply at amgenscholars.com.
As the COVID-19 pandemic continues to evolve, Amgen is committed to doing everything we can to deliver for patients, to keep our staff and their families safe, and to help communities where we live and work to reduce the number of people exposed to the virus.
In these unprecedented times, Amgen Hong Kong have supported vulnerable groups, patient organizations and frontline healthcare professionals through donations. We have worked with patient organizations to enhance their digital platforms and assisted patients with safe and compliant treatment administration. Through digital platforms, we also strengthened communications with patients and provided health tips to help patients to remain physically active during the lockdown period. Amgen Hong Kong not only increased the frequency of alerts on its patient reminder services to ensure treatment consistency, but also supported a nongovernmental organization to build a virtual learning platform that enables patients to continue their rehabilitation activities.
Furthermore, Amgen and the Amgen Foundation have committed to US$1 million to support COVID-19 relief efforts in the Asia Pacific region and address critical needs in local communities impacted by the pandemic. Amgen and the Amgen Foundation contribute to international relief efforts by Direct Relief and International Medical Corps, two early responders to the COVID-19 outbreak in China.
The Amgen Foundation is also matching donations made by Amgen staff worldwide who wish to contribute to their own funds to relief efforts. Additionally, the Foundation is a proud sponsor of two online learning platforms – Khan Academy and LabXchange – which provide free world-class educational content to students around the world at a time when many can no longer go to school.
HK-08413-AMGEN-2022-Jun
Date of Approval: June 2022